- Home
- MBX vs MBAV Comparison
MBX vs MBAV Comparison
Compare MBX & MBAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBX
- MBAV
- Stock Information
- Founded
- MBX 2018
- MBAV 2024
- Country
- MBX United States
- MBAV United States
- Employees
- MBX N/A
- MBAV N/A
- Industry
- MBX
- MBAV
- Sector
- MBX
- MBAV
- Exchange
- MBX NYSE
- MBAV NYSE
- Market Cap
- MBX 381.4M
- MBAV 413.3M
- IPO Year
- MBX 2024
- MBAV 2024
- Fundamental
- Price
- MBX $13.29
- MBAV $11.00
- Analyst Decision
- MBX Strong Buy
- MBAV
- Analyst Count
- MBX 5
- MBAV 0
- Target Price
- MBX $37.40
- MBAV N/A
- AVG Volume (30 Days)
- MBX 365.8K
- MBAV 609.4K
- Earning Date
- MBX 08-16-2025
- MBAV 01-01-0001
- Dividend Yield
- MBX N/A
- MBAV N/A
- EPS Growth
- MBX N/A
- MBAV N/A
- EPS
- MBX N/A
- MBAV 0.28
- Revenue
- MBX N/A
- MBAV N/A
- Revenue This Year
- MBX N/A
- MBAV N/A
- Revenue Next Year
- MBX N/A
- MBAV N/A
- P/E Ratio
- MBX N/A
- MBAV $39.72
- Revenue Growth
- MBX N/A
- MBAV N/A
- 52 Week Low
- MBX $4.81
- MBAV $9.97
- 52 Week High
- MBX $27.50
- MBAV $13.73
- Technical
- Relative Strength Index (RSI)
- MBX N/A
- MBAV N/A
- Support Level
- MBX N/A
- MBAV N/A
- Resistance Level
- MBX N/A
- MBAV N/A
- Average True Range (ATR)
- MBX 0.00
- MBAV 0.00
- MACD
- MBX 0.00
- MBAV 0.00
- Stochastic Oscillator
- MBX 0.00
- MBAV 0.00
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
About MBAV M3-BRIGADE ACQUISITION V CORP
M3-Brigade Acquisition V Corp is a blank check company.